The Vault series

Insight on what matters - so you can transform your business.

BIOPHARMA DEALMAKERS – WHAT'S AN ECTD, AND WHY SHOULD YOU CARE?

13 July 2016

Experienced biopharma dealmakers know that pharma companies seeking to partner with a biotech will require full disclosure of the regulatory submission documents. During due diligence, they will need...

SHAREVAULT & IRIS ANNOUNCE STRATEGIC ALLIANCE TO PROVIDE END-TO-END PRODUCT MANAGEMENT SOLUTION FOR LIFE SCIENCES

06 June 2016

Los Gatos, CA — ShareVault, an industry-leading provider of life science virtual data rooms, along with IRIS Interactive, a leading provider of proven software which enables life science companies to...

How to Organize a Due Diligence List for BioPharma Partnering

05 November 2015

Given the rapid pace of innovation in today’s Life Science industry it has become more important than ever for biotech companies to align themselves with strategic partners in order to advance their...

GENE EDITING FOR RARE DISORDERS: HOW PROMISING IS IT?

12 October 2015

The ability to modify the nucleotide sequence of a genome with precision is a critical aspect of genome editing. That's been the challenge. But in the last five years great strides have been made as...

5 INDICATIONS THAT NEW GENE THERAPIES FOR RARE DISORDERS IS A BUNNY THAT’S NOT GOING BACK IN THE BOX [PIE CHART]

19 August 2015

Exciting new gene and cell therapy technologies have the potential to treat devastating inherited diseases and rare disorders for which there is little hope of finding a conventional cure. Recent...

7 REASONS BIOTECH COMPANIES USE SHAREVAULT FOR PARTNERING & LICENSING

03 August 2015

Although today’s biotech industry venture funding levels are among the strongest in the sector’s history, some things haven't changed—the volatility resulting from constant innovation, uncertain...

THE VIRTUES OF THE VIRTUAL BIOTECH

27 April 2015

How many people does it take to run a successful biotech company? The traditional model of the biotech company in the glass-fronted building with a sparkling fountain out front and employing a...

CROWDFUNDING? FOR LIFE SCIENCE COMPANIES? REALLY?

02 February 2015

After extremely weak performance in early 2014, the biotechnology industry understandably dropped off the radar of many investors. And, even though the industry has quietly been making a comeback,...

10 COMMON BIOTECH PARTNERING MYTHS, EXPOSED

15 January 2015

Biotech companies know that it’s essential to align with strategic partners to advance their drug candidates to market. But for the small biotech company the partnering process can sometimes be...

YOU WANT TO PARTNER, BUT WHAT’S YOUR EARLY DRUG CANDIDATE WORTH?

25 November 2014

Biotechnology companies rely heavily on alliances with pharmaceutical companies to finance their research and development expenditures, and pharmaceutical firms rely heavily on alliances to...

The Seven Habits of Highly Effective Data Rooms

View More

Popular Posts

Stay up to date on the latest industry tips and advice